TR2Lab creates a new research line in Molecular Photopharmacology, leaded by Dr. Xavier Rovira
Proud to create a new research line focused on Molecular Photopharmacology. The recent recruitment of Dr. Xavier Rovira, an expert in the field of optopharmacology, has allowed the TR2Lab creates an emerging research line focused on developing new advanced photopharmacological therapies for cardiovascular diseases. Check out more information under Research